| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Mengzhou Xue | Q123457202 |
| Dongdong Wu | Q52669277 | ||
| Ailing Ji | Q87895000 | ||
| Yanzhang Li | Q87895004 | ||
| P2093 | author name string | Hui Li | |
| Jun Wang | |||
| P2860 | cites work | Design and synthesis of polymeric hydrogen sulfide donors | Q88106978 |
| Design, synthesis and biological evaluation of hydrogen sulfide releasing derivatives of 3-n-butylphthalide as potential antiplatelet and antithrombotic agents | Q88204611 | ||
| Hydrogen sulfide mediates the vasoactivity of garlic | Q24673752 | ||
| Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease | Q26823796 | ||
| Hydrogen sulfide chemical biology: pathophysiological roles and detection | Q26824672 | ||
| The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning | Q26825733 | ||
| Historical perspective on the pathology of myocardial ischemia/reperfusion injury | Q27010509 | ||
| H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase | Q28298435 | ||
| A new slow releasing, H₂S generating compound, GYY4137 relaxes spontaneous and oxytocin-stimulated contractions of human and rat pregnant myometrium | Q28484072 | ||
| Therapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat model | Q28485947 | ||
| Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion | Q28508488 | ||
| Hydrogen sulfide releasing aspirin, ACS14, attenuates high glucose-induced increased methylglyoxal and oxidative stress in cultured vascular smooth muscle cells | Q28539333 | ||
| Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R | Q28576521 | ||
| Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function | Q30480176 | ||
| Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury | Q30489935 | ||
| Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. | Q30491252 | ||
| Using a functional enzyme model to understand the chemistry behind hydrogen sulfide induced hibernation. | Q30492583 | ||
| Hydrogen sulfide is an endogenous stimulator of angiogenesis. | Q30492603 | ||
| Redox biochemistry of hydrogen sulfide | Q30495475 | ||
| Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice | Q30497008 | ||
| Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies | Q31086283 | ||
| Differential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress | Q33692977 | ||
| Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy | Q33696105 | ||
| Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases | Q33707944 | ||
| Hydrogen sulfide ameliorates ischemia/reperfusion-induced hepatitis by inhibiting apoptosis and autophagy pathways | Q33747476 | ||
| mTORC2 phosphorylation of Akt1: a possible mechanism for hydrogen sulfide-induced cardioprotection | Q33783826 | ||
| Hydrogen sulfide treatment ameliorates long-term renal dysfunction resulting from prolonged warm renal ischemia-reperfusion injury | Q33843682 | ||
| Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice | Q33874591 | ||
| Protective Effect and Mechanism of Total Flavones from Rhododendron simsii Planch on Endothelium-Dependent Dilatation and Hyperpolarization in Cerebral Ischemia-Reperfusion and Correlation to Hydrogen Sulphide Release in Rats | Q33876288 | ||
| H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S? | Q33954567 | ||
| Time-dependent Gene Profiling Indicates the Presence of Different Phases for Ischemia/Reperfusion Injury in Retina | Q34109774 | ||
| NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model | Q34256975 | ||
| Differential effects of cystathionine-γ-lyase-dependent vasodilatory H2S in periadventitial vasoregulation of rat and mouse aortas | Q34369157 | ||
| Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition. | Q34402692 | ||
| Hydrogen sulfide targets EGFR Cys797/Cys798 residues to induce Na(+)/K(+)-ATPase endocytosis and inhibition in renal tubular epithelial cells and increase sodium excretion in chronic salt-loaded rats | Q34431778 | ||
| AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro | Q34477537 | ||
| Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance | Q34559610 | ||
| Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolism | Q34722817 | ||
| Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. | Q34992435 | ||
| Hydrogen sulfide preconditioning protects rat liver against ischemia/reperfusion injury by activating Akt-GSK-3β signaling and inhibiting mitochondrial permeability transition | Q34994670 | ||
| Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction | Q46446506 | ||
| Protective effects of diallyl sulfide, a garlic constituent, on the warm hepatic ischemia-reperfusion injury in a rat model. | Q46484123 | ||
| Synthesis of a photocontrollable hydrogen sulfide donor using ketoprofenate photocages | Q46508139 | ||
| Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria. | Q46583629 | ||
| Hydrogen sulfide protects rat lung from ischemia-reperfusion injury | Q46593773 | ||
| Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury | Q46603540 | ||
| Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart | Q46612420 | ||
| Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide | Q46621665 | ||
| Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. | Q46735649 | ||
| Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels | Q46835777 | ||
| Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of Brassicaceae? | Q46874690 | ||
| CYP2J2 and EETs Protect against Oxidative Stress and Apoptosis in Vivo and in Vitro Following Lung Ischemia/Reperfusion. | Q46883529 | ||
| Strain-specific differences in sensitivity to ischemia-reperfusion lung injury in mice | Q46913652 | ||
| Cyclooxygenase-2 mediates the delayed cardioprotection induced by hydrogen sulfide preconditioning in isolated rat cardiomyocytes | Q46976895 | ||
| Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player? | Q48034814 | ||
| Dynamic change of hydrogen sulfide during global cerebral ischemia-reperfusion and its effect in rats | Q48195052 | ||
| Exogenous hydrogen sulfide protects against global cerebral ischemia/reperfusion injury via its anti-oxidative, anti-inflammatory and anti-apoptotic effects in rats | Q48309111 | ||
| Hydrogen sulphide attenuates renal and cardiac injury after total hepatic ischemia and reperfusion | Q48321645 | ||
| N-Acetylcysteine ethyl ester (NACET): a novel lipophilic cell-permeable cysteine derivative with an unusual pharmacokinetic feature and remarkable antioxidant potential. | Q48366429 | ||
| Hydrogen sulfide treatment induces angiogenesis after cerebral ischemia | Q48710378 | ||
| Neuroprotective effects of diallyl sulfide against transient focal cerebral ischemia via anti-apoptosis in rats | Q48752925 | ||
| Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia | Q50224206 | ||
| Inhalative preconditioning with hydrogen sulfide attenuated apoptosis after retinal ischemia/reperfusion injury. | Q35012464 | ||
| Hydrogen sulfide and hemeproteins: knowledge and mysteries | Q35055729 | ||
| Ischemia-reperfusion-induced lung injury. | Q35067234 | ||
| Cardiovascular remodelling in coronary artery disease and heart failure | Q35090566 | ||
| Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo | Q35181925 | ||
| Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats | Q35204841 | ||
| Retinal ischemia: mechanisms of damage and potential therapeutic strategies | Q35650660 | ||
| Isoflurane post-conditioning protects against intestinal ischemia-reperfusion injury and multiorgan dysfunction via transforming growth factor-β1 generation | Q35785575 | ||
| Hydrogen sulfide in biochemistry and medicine | Q35929408 | ||
| Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo | Q36025402 | ||
| The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability | Q36042694 | ||
| Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis | Q36052635 | ||
| Retinal ganglion cell death and optic nerve degeneration by genetic ablation in adult mice | Q36099982 | ||
| The role of AKT1 and autophagy in the protective effect of hydrogen sulphide against hepatic ischemia/reperfusion injury in mice | Q36187789 | ||
| Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants. | Q36203242 | ||
| A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death | Q36234796 | ||
| The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart. | Q36381503 | ||
| Hydrogen sulfide reduces neutrophil recruitment in hind-limb ischemia-reperfusion injury in an L-selectin and ADAM-17-dependent manner | Q36654084 | ||
| The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury | Q36713900 | ||
| Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress | Q36796570 | ||
| Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner | Q36838022 | ||
| Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling | Q36844600 | ||
| H₂S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase | Q36895184 | ||
| Hydrogen sulfide treatment promotes glucose uptake by increasing insulin receptor sensitivity and ameliorates kidney lesions in type 2 diabetes | Q36913158 | ||
| The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization. | Q36915584 | ||
| Hydrogen sulfide-releasing anti-inflammatory drugs | Q36947513 | ||
| Progressive morphological changes and impaired retinal function associated with temporal regulation of gene expression after retinal ischemia/reperfusion injury in mice | Q36964484 | ||
| Hydrogen sulphide and its therapeutic potential | Q36975742 | ||
| VEGFR2 functions as an H2S-targeting receptor protein kinase with its novel Cys1045-Cys1024 disulfide bond serving as a specific molecular switch for hydrogen sulfide actions in vascular endothelial cells | Q36991383 | ||
| H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G | Q37002373 | ||
| Controllable hydrogen sulfide donors and their activity against myocardial ischemia-reperfusion injury | Q37097747 | ||
| Hydrogen sulfide mediates cardioprotection through Nrf2 signaling | Q37328256 | ||
| Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells. | Q37371516 | ||
| Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. | Q37379431 | ||
| Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications. | Q38229082 | ||
| Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by Keap1 s-sulfhydration, MAPK dependent anti-apoptosis and NF-κB dependent anti-inflammation pathway | Q39032766 | ||
| NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders | Q39114886 | ||
| Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats | Q39197576 | ||
| The gasotransmitter hydrogen sulfide induces nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between cys-226 and cys-613. | Q39245992 | ||
| Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice. | Q39255899 | ||
| Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat. | Q39291389 | ||
| Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer. | Q39375950 | ||
| Glutamate oxidative injury to RGC-5 cells in culture is necrostatin sensitive and blunted by a hydrogen sulfide (H2S)-releasing derivative of aspirin (ACS14). | Q39401348 | ||
| Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity | Q39418780 | ||
| Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo | Q39419473 | ||
| S-Propargyl-cysteine (SPRC) attenuated lipopolysaccharide-induced inflammatory response in H9c2 cells involved in a hydrogen sulfide-dependent mechanism. | Q39595060 | ||
| Therapeutic delivery of hydrogen sulfide for salvage of ischemic skeletal muscle after the onset of critical ischemia. | Q39610769 | ||
| Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease. | Q39718802 | ||
| Acute kidney injury, mortality, length of stay, and costs in hospitalized patients | Q39730814 | ||
| Molecular mechanism for H(2)S-induced activation of K(ATP) channels | Q39796958 | ||
| Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). | Q39884340 | ||
| Compared effects of inhibition and exogenous administration of hydrogen sulphide in ischaemia-reperfusion injury | Q40690240 | ||
| Involvement of miR-1 in the protective effect of hydrogen sulfide against cardiomyocyte apoptosis induced by ischemia/reperfusion | Q41166546 | ||
| Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid. | Q41556578 | ||
| Protective effect of endogenous hydrogen sulfide against oxidative stress in gastric ischemia-reperfusion injury | Q41828048 | ||
| Cysteine-activated hydrogen sulfide (H2S) donors. | Q42005921 | ||
| Hydrogen sulfide postconditioning protects isolated rat hearts against ischemia and reperfusion injury mediated by the JAK2/STAT3 survival pathway | Q42126362 | ||
| Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential | Q42159113 | ||
| Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats. | Q42913506 | ||
| Hypoxia in the renal medulla: implications for hydrogen sulfide signaling. | Q43081728 | ||
| Retinal protection from acute glaucoma-induced ischemia-reperfusion injury through pharmacologic induction of heme oxygenase-1. | Q43112915 | ||
| Modulation of thiol homeostasis induced by H2S-releasing aspirin | Q43156037 | ||
| L-cysteine stimulates hydrogen sulfide synthesis in myocardium associated with attenuation of ischemia-reperfusion injury. | Q43172655 | ||
| Hydrogen sulphide ameliorates ischaemia-reperfusion injury in an experimental model of non-heart-beating donor kidney transplantation | Q43208262 | ||
| Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H(2)S production. | Q43258277 | ||
| Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats | Q43269344 | ||
| ACS67, a hydrogen sulfide-releasing derivative of latanoprost acid, attenuates retinal ischemia and oxidative stress to RGC-5 cells in culture | Q43285272 | ||
| Cardioprotective effect of hydrogen sulfide in ischemic reperfusion experimental rats and its influence on expression of survivin gene | Q43299185 | ||
| CBS and CSE are critical for maintenance of mitochondrial function and glucocorticoid production in adrenal cortex | Q43761802 | ||
| Allitridum mimics effect of ischemic preconditioning by activation of protein kinase C. | Q43821306 | ||
| Protective effect of S-allyl-L-cysteine against endoplasmic reticulum stress-induced neuronal death is mediated by inhibition of calpain | Q44108167 | ||
| A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells | Q44131370 | ||
| Hydrogen sulfide prevents ethanol-induced gastric damage in mice: role of ATP-sensitive potassium channels and capsaicin-sensitive primary afferent neurons. | Q44572022 | ||
| Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection. | Q45924442 | ||
| Ischemia-reperfusion reduces cystathionine-beta-synthase-mediated hydrogen sulfide generation in the kidney. | Q46013974 | ||
| Role of paraoxonase-1 in the protection of hydrogen sulfide-donating sildenafil (ACS6) against homocysteine-induced neurotoxicity | Q46041979 | ||
| Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: an in vivo study. | Q46046894 | ||
| New prostaglandin derivative for glaucoma treatment | Q46114087 | ||
| CaMKKβ-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation | Q46124072 | ||
| Hydrogen sulfide protects from intestinal ischaemia-reperfusion injury in rats | Q46141153 | ||
| The mechanism of sevoflurane preconditioning-induced protections against small intestinal ischemia reperfusion injury is independent of mast cell in rats | Q37403015 | ||
| The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia/reperfusion damage | Q37436749 | ||
| Ischemia and reperfusion--from mechanism to translation | Q37455225 | ||
| Production and physiological effects of hydrogen sulfide. | Q37544124 | ||
| Adalimumab ameliorates abdominal aorta cross clamping which induced liver injury in rats. | Q37556557 | ||
| Biomarkers in renal transplantation ischemia reperfusion injury | Q37577218 | ||
| Hydrogen sulfide activation in hemeproteins: the sulfheme scenario | Q37691508 | ||
| Hydrogen sulfide improves wound healing via restoration of endothelial progenitor cell functions and activation of angiopoietin-1 in type 2 diabetes | Q37715592 | ||
| The protective effect of genistein postconditioning on hypoxia/reoxygenation-induced injury in human gastric epithelial cells | Q37728929 | ||
| S-propargyl-cysteine, a novel water-soluble modulator of endogenous hydrogen sulfide, promotes angiogenesis through activation of signal transducer and activator of transcription 3. | Q37734005 | ||
| Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process | Q37787682 | ||
| The therapeutic potential of ischemic conditioning: an update | Q37892335 | ||
| Hydrogen sulphide: biopharmacological roles in the cardiovascular system and pharmaceutical perspectives | Q38017235 | ||
| Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury | Q38030379 | ||
| Ischaemia-reperfusion injury in liver transplantation--from bench to bedside | Q38066361 | ||
| Mitophagy in ischaemia/reperfusion induced cerebral injury | Q38096954 | ||
| Current knowledge on oxidative stress in hepatic ischemia/reperfusion | Q38112166 | ||
| Redox Biology of Hydrogen Sulfide: Implications for Physiology, Pathophysiology, and Pharmacology | Q38116513 | ||
| Chemical foundations of hydrogen sulfide biology | Q38121347 | ||
| Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition. | Q38175226 | ||
| The physiological role of hydrogen sulfide and beyond | Q38184673 | ||
| Global consequences of liver ischemia/reperfusion injury. | Q38209664 | ||
| Hydrogen sulfide and nitric oxide interactions in inflammation | Q38220215 | ||
| Dysregulation of hydrogen sulphide metabolism impairs oviductal transport of embryos. | Q50656589 | ||
| Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice. | Q51068380 | ||
| Effects of hydrogen sulphide in an experimental model of renal ischaemia-reperfusion injury. | Q51298127 | ||
| Hydrogen sulfide attenuates intestinal ischemia-reperfusion injury when delivered in the post-ischemic period. | Q53269440 | ||
| Real time measurement of myocardial oxygen dynamics during cardiac ischemia-reperfusion of rats. | Q53359262 | ||
| Hydrogen sulfide protects cardiomyocytes from myocardial ischemia-reperfusion injury by enhancing phosphorylation of apoptosis repressor with caspase recruitment domain. | Q54517566 | ||
| Thioglycine and l-thiovaline: Biologically active H2S-donors | Q60695399 | ||
| Gastrointestinal Safety and Anti-Inflammatory Effects of a Hydrogen Sulfide–Releasing Diclofenac Derivative in the Rat | Q60695408 | ||
| 5-Amino-2-hydroxybenzoic Acid 4-(5-Thioxo-5H-[1,2]dithiol-3yl)-phenyl Ester (ATB-429), a Hydrogen Sulfide-Releasing Derivative of Mesalamine, Exerts Antinociceptive Effects in a Model of Postinflammatory Hypersensitivity | Q60695409 | ||
| Hydrogen Sulfide Protects the Brain Against Ischemic Reperfusion Injury in a Transient Model of Focal Cerebral Ischemia | Q63343215 | ||
| The protective role of hydrogen sulfide in myocardial ischemia–reperfusion-induced injury in diabetic rats | Q63859553 | ||
| The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat | Q80027203 | ||
| Treatment with H2S-releasing diclofenac protects mice against acute pancreatitis-associated lung injury | Q80590460 | ||
| Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways | Q80732265 | ||
| Therapeutic metabolic inhibition: hydrogen sulfide significantly mitigates skeletal muscle ischemia reperfusion injury in vitro and in vivo | Q82698966 | ||
| Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP | Q82891752 | ||
| Sodium hydrosulfide improves the protective potential of the cardioplegic histidine buffer solution | Q83032291 | ||
| Gastroprotective effect of NaHS against mucosal lesions induced by ischemia-reperfusion injury in rat | Q83311269 | ||
| Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion | Q83891093 | ||
| Beneficial effects of gaseous hydrogen sulfide in hepatic ischemia/reperfusion injury | Q84419278 | ||
| Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury | Q84596416 | ||
| Participation of autophagy in lung ischemia-reperfusion injury in vivo | Q85633167 | ||
| S-aroylthiooximes: a facile route to hydrogen sulfide releasing compounds with structure-dependent release kinetics | Q87370467 | ||
| Hydrogen sulfide-releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo | Q87397480 | ||
| Detrimental effects of prolonged warm renal ischaemia-reperfusion injury are abrogated by supplemental hydrogen sulphide: an analysis using real-time intravital microscopy and polymerase chain reaction | Q87418850 | ||
| Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer | Q87713329 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | hydrogen sulfide | Q170591 |
| myocardial reperfusion injury | Q54971821 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 186908 | |
| P577 | publication date | 2015-05-12 | |
| P1433 | published in | Oxidative medicine and cellular longevity | Q26840015 |
| P1476 | title | Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury | |
| P478 | volume | 2015 |
| Q92493115 | A New Approach for the Prevention and Treatment of Cardiovascular Disorders. Molecular Hydrogen Significantly Reduces the Effects of Oxidative Stress |
| Q90285254 | Activatable Small-Molecule Hydrogen Sulfide Donors |
| Q33873758 | Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models. |
| Q47102811 | Caenorhabditis elegans HIF-1 Is Broadly Required for Survival in Hydrogen Sulfide |
| Q92998230 | Effect of Different Doses and Times of FK506 on Different Areas of the Hippocampus in the Rat Model of Transient Global Cerebral Ischemia-Reperfusion |
| Q92929300 | Exogenous Hydrogen Sulfide Regulates the Growth of Human Thyroid Carcinoma Cells |
| Q37060073 | Hydrogen Sulfide Mitigates Kidney Injury in High Fat Diet-Induced Obese Mice. |
| Q64230679 | Hydrogen Sulfide as a Novel Regulatory Factor in Liver Health and Disease |
| Q28087344 | Hydrogen Sulfide in Physiology and Diseases of the Digestive Tract |
| Q60947878 | Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis |
| Q33673500 | Hydrogen sulfide ameliorates chronic renal failure in rats by inhibiting apoptosis and inflammation through ROS/MAPK and NF-κB signaling pathways. |
| Q94663974 | Hydrogen sulfide and its donors: Novel antitumor and antimetastatic therapies for triple-negative breast cancer |
| Q51758188 | Hydrogen sulfide in physiology and pathogenesis of bacteria and viruses. |
| Q39458459 | Hydrogen sulfide therapy in brain diseases: from bench to bedside |
| Q47161351 | Inhibition of Caveolae Contributes to Propofol Preconditioning-Suppressed Microvesicles Release and Cell Injury by Hypoxia-Reoxygenation |
| Q90927584 | Molecular strategies used by hibernators: Potential therapeutic directions for ischemia reperfusion injury and preservation of human donor organs |
| Q91896679 | Protective Role of mTOR in Liver Ischemia/Reperfusion Injury: Involvement of Inflammation and Autophagy |
| Q99567356 | Protective effects of dexmedetomidine on hypoxia/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway |
| Q89467744 | Raised plasma levels of H2S and nitrate predict intrapulmonary vascular dilations: A preliminary report in patients with cryptogenic cirrhosis |
| Q38655965 | The anti-inflammatory and anti-apoptotic effects of gallic acid against mucosal inflammation- and erosions-induced by gastric ischemia-reperfusion in rats |
| Q52603995 | The route and timing of hydrogen sulfide therapy critically impacts intestinal recovery following ischemia and reperfusion injury. |
Search more.